Open AccessTo a problem of the markers of vessels wall at EPH-gestosis
Author(s) -
E. K. Ailamasian,
М. С. Зайнулина,
N. N. Petrishev
Publication year - 1998
Publication title -
žurnalʺ akušerstva i ženskihʺ boleznej
Language(s) - English
Resource type - Journals
eISSN - 1684-0461
pISSN - 1683-9366
DOI - 10.17816/jowd86949
Subject(s) - medicine , von willebrand factor , pregnancy , platelet , erythropoietin producing hepatocellular (eph) receptor , endothelium , endocrinology , andrology , obstetrics , receptor , biology , genetics , receptor tyrosine kinase
Content in blood of markers of damage of a vessel wall (factor Willebrand, tissue of a catalyst plasminogen, cells circulating in blood endothelium), and also intravessel an aggregate platelet and uterine - placental bloodcurrent at 205 patients, among which woman with physiological current of pregnancy and with EPH-gestosis of a various degree of weight is investigated. The patients with nephropathy and preeclampsy were divided into groups depending on a method of treatment.
The 46 pregnant with EPH-gestosis of a various degree of weight was carried by clofelin in a daily doze 0,00015-0,0003 g during 7-10 days, 42 women therapy (the course doze 25,5-27 g of dry substance) is spent magnesium, 59 pregnant received clofelin and magnesium therapy in the above-stated dozes. The group of comparison formed 38 patients.
It was shown the important value of a research of markers of damage endothelium for diagnostics, definition of a degree of weight and control for efficiency of therapy pregnant with EPH-gestosis. Clofelin and magnesium, used for treatment of pregnant with EPH-gestosis as is independent, and in a combination, have endotheliumprotection operation, as reduce in authentic decrease of a content in blood of a marker of vessel's disorders of circulating cells endothelium, and also reduce intravessel an aggregate of platelets and improve uterine-placental bloodcurrent.